| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.06 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.3 | 0.06 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |